MICROBIOCHIP DIAGNOSTICS LLC

El Paso, TX · Medtech · Private

Paper/polymer hybrid microfluidic point-of-care diagnostic device integrated with loop-mediated isothermal DNA amplification (LAMP) for rapid detection of Bordetella pertussis and B. parapertussis

Grants
$522K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Point-of-care microdevices for simultaneous detection of multiple pertussis-like respiratory diseases from Bordetella species$390,952
Federal grantDepartment of Health and Human Services · Phase I · Point-of-care microdevices for simultaneous detection of multiple pertussis-like respiratory diseases from Bordetella species$131,387
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1963GAiTE LLC——
1964CHARLES RIVER ANALYTICS, INC.——
1965NYTRICX INC——
1966MICROBIOCHIP DIAGNOSTICS LLC——
1967LXS, LLC——
1968PNEUMICO, LLC——
1969Q'Apel Medical, Inc.—$68M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.